Paperpal Prime Logo

Clinical Pharmacokinetics : Impact Factor & More

eISSN: 1179-1926pISSN: 0312-5963

Key Metrics

CiteScore
10.3
Eigenfactor
0.005 - 0.01
Impact Factor
< 5
SJR
Q1Pharmacology
SNIP
2.16
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Clinical Pharmacokinetics

Clinical Pharmacokinetics Journal Specifications

Overview
Publisher ADIS INT LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1976
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Clinical Pharmacokinetics ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Clinical Pharmacokinetics

How Feasible is the Use of Saliva for Antiviral Therapeutic Drug Monitoring? A Systematic Review and Analysis.
  • 5 Aug 2026
  • Clinical pharmacokinetics
Exposure-Response Analyses to Inform the Optimal Epcoritamab Monotherapy Dosing Regimen in Relapsed or Refractory Follicular Lymphoma.
  • 1 Aug 2026
  • Clinical pharmacokinetics
Simulation-Based Predictions to Support the Development of a Pediatric Fixed-Dose Combination of Dolutegravir/Emtricitabine/Tenofovir Alafenamide Fumarate.
  • 30 Jul 2026
  • Clinical pharmacokinetics
Correction: Population Pharmacokinetic Analysis of Enalapril and Enalaprilat in Newly Treated Children with Heart Failure: Implications for Safe Dosing of Enalapril (LENA Studies).
  • 29 Jul 2026
  • Clinical pharmacokinetics
Physiologically Based Pharmacokinetic Modeling of Vedolizumab in Healthy Adults and Patients with Inflammatory Bowel Disease.
  • 27 Jul 2026
  • Clinical pharmacokinetics
The Effect of Food and the Proton Pump Inhibitor Rabeprazole on Binimetinib Pharmacokinetics in Healthy Participants.
  • 27 Jul 2026
  • Clinical pharmacokinetics
How Feasible is the Use of Saliva for Antiviral Therapeutic Drug Monitoring? A Systematic Review and Analysis.
  • 5 Aug 2026
  • Clinical pharmacokinetics
Exposure-Response Analyses to Inform the Optimal Epcoritamab Monotherapy Dosing Regimen in Relapsed or Refractory Follicular Lymphoma.
  • 1 Aug 2026
  • Clinical pharmacokinetics
Simulation-Based Predictions to Support the Development of a Pediatric Fixed-Dose Combination of Dolutegravir/Emtricitabine/Tenofovir Alafenamide Fumarate.
  • 30 Jul 2026
  • Clinical pharmacokinetics
Correction: Population Pharmacokinetic Analysis of Enalapril and Enalaprilat in Newly Treated Children with Heart Failure: Implications for Safe Dosing of Enalapril (LENA Studies).
  • 29 Jul 2026
  • Clinical pharmacokinetics
Physiologically Based Pharmacokinetic Modeling of Vedolizumab in Healthy Adults and Patients with Inflammatory Bowel Disease.
  • 27 Jul 2026
  • Clinical pharmacokinetics
The Effect of Food and the Proton Pump Inhibitor Rabeprazole on Binimetinib Pharmacokinetics in Healthy Participants.
  • 27 Jul 2026
  • Clinical pharmacokinetics

FAQs on Clinical Pharmacokinetics